[email protected]
CAS 26575-95-1 Alisol B acetate molecular structure lightbox
CAS RN: 26575-95-1

Alisol B acetate

Product Availability

Choose a grade to view its available package options.

9 package records6 with current stock3 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250611 100mg In stock Inquiry
Batchno.20250405 10mg In stock Inquiry
Batchno.20250707 25mg In stock Inquiry
Batchno.20250925 50mg In stock Inquiry
Batchno.20260409 5mg In stock Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250412 10mg / 25mg / 100mg Out of stock 5-7 business days Inquiry
Batchno.20260602 25mg Out of stock Inquiry
Batchno.20251015 5mg Out of stock Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250907 20mg In stock Shanghai, Shandong Inquiry
  • Product code: starshine_CAS26575-95-1
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

26575-95-1 / [1-(3,3-dimethyloxiran-2-yl)-3-[(8S,10S,11S,14R)-11-hydroxy-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]butyl] acetate

Standard CAS: 26575-95-1 Multi CAS: No
Basic Information Computed Properties

Basic Information

CAS
26575-95-1
Multi CAS
No
Molecular Formula
C32H50O5
Molecular Weight
514.700000
Exact Mass
514.365825
SMILES
CC(CC(C1C(O1)(C)C)OC(=O)C)C2=C3C[C@@H](C4[C@]5(CCC(=O)C(C5CC[C@@]4([C@]3(CC2)C)C)(C)C)C)O
InChI
InChI=1S/C32H50O5/c1-18(16-23(36-19(2)33)27-29(5,6)37-27)20-10-14-31(8)21(20)17-22(34)26-30(7)13-12-25(35)28(3,4)24(30)11-15-32(26,31)9/h18,22-24,26-27,34H,10-17H2,1-9H3/t18-,22+,23+,24+,26+,27-,30+,31+,32+/m1/s1
InChIKey
NLOAQXKIIGTTRE-JSWHPQHOSA-N

Computed Properties

Structural Parameters

Heavy atom count
37
Fraction Csp3
0.88
Rotatable bonds
5
H-bond acceptors
5
H-bond donors
1
Molar refractivity
143.73
TPSA
76.13

LogP / Solubility

WLOGP
6.41
MLOGP
5.68
XLogP3
5.4
Consensus LogP
5.83
Log S (ESOL)
-6.74
Class (ESOL)
Insoluble
Log S (Ali)
-8.41
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-8.93
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.31

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
9.5

Customers Also Viewed

Get In Touch

Contact Us